targeted therapies (i.e.: multi-kinase inhibitors, ret, ntrk inhibitors) in advanced disease. 251
Published 1 year ago • 244 plays • Length 57:12
Download video MP4
Download video MP3
Similar videos
-
54:31
targeted therapies advanced differentiated thyroid cancer with dr. gianoukakis
-
1:15:45
when should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
-
53:24
thyroid cancer: targeted therapies for progressing metastases. dr. schweppe. thyca conference
-
48:17
251 future treatments &emerging & future trials for advanced papillary, follicular, pdtc or atc
-
1:07:53
biomarker testing. advanced cancer needing tests to look for ntrk, ret & other therapeutic targets.
-
6:57
tki therapy for advanced thyroid cancer
-
59:14
171 developing a new targeted therapy combination for rai-r thyroid cancers & atc: a clinical trial
-
4:57
selpercatinib benefit for advanced, kinase inhibitor-naïve, ret-mutant medullary thyroid cancer
-
1:00:23
medullary thyroid cancer targeted therapy with dr zafereo 163
-
4:15
multikinase inhibitor overall survival advantage
-
57:51
surgery rai & now rai resistant. when should i test for ntrk, ret, other therapeutic targets? 242
-
41:48
novel chemotherapies for metastatic papillary, follicular, or hurthle cell thyroid cancer
-
45:58
thyroid cancer: complexity, results at center for personalized cancer therapeutics. dr. smibert.
-
10:29
targeted therapy for ntrk fusion-positive cancers
-
4:27
entrectinib: a review in ntrk solid tumours and ros1 nsclc
-
57:15
212 drugs in development for rai-refractory differentiated thyroid cancer. new molecular targets
-
6:12
early versus delayed use of tyrosine kinase inhibitors for thyroid cancer
-
0:52
selecting egfr tyrosine kinase inhibitors for egfr-mutant lung cancer
Clip.africa.com - Privacy-policy